Altimmune, Inc. (ALT)
5.38
+0.76
(+16.45%)
USD |
NASDAQ |
Jan 22, 16:00
5.54
+0.16
(+2.97%)
After-Hours: 20:00
Altimmune Research and Development Expense (TTM): 67.72M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Viking Therapeutics, Inc. | 222.48M |
| CorMedix, Inc. | 12.46M |
| Actinium Pharmaceuticals, Inc. | 20.82M |
| Aldeyra Therapeutics, Inc. | 35.99M |
| Seres Therapeutics, Inc. | 50.22M |